Continuous Negative External Pressure for the Treatment of Primary Snoring
- Conditions
- Snoring
- Registration Number
- NCT03372070
- Lead Sponsor
- Sommetrics, Inc.
- Brief Summary
The aim of this pilot study is to gain information on the ability of a continuous negative external pressure collar to safely reduce snoring in primary snorers, and if so to determine whether the reduction in snoring has benefits for both the snorer and the bed partner. This clinical trial will involve both the snorer and his or her bed partner, both of whom must qualify and provide informed consent for participation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- BMI <35
- if a previously done polysomnogram (PSG) is available, AHI<5
- snoring identified by a previous PSG and/or by the bed partner
Key bed partner Inclusion criteria
- must have regularly slept with the snorer over the previous month and must plan to sleep with the snorer for the duration of the trial
- considers that the snorer's snoring is a problem
- must discontinue use of any snore-masking equipment or ear plug for at least two weeks prior to the initial visit to the study site and agree to refrain from their use for the duration of the trial
Key snorer exclusion criteria:
- sleep disturbance other than snoring
- snoring due primarily to abnormality of the nasopharynx
- use of snoring treatment during the month prior to the initial visit
- neck anatomic or skin abnormalities
- serious medical condition
- excessive drug or alcohol intake
Key bed partner exclusion criteria:
-known sleep disorder
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method change in snoring duration two weeks after initiation of treatment duration of snoring as a percent of total sleep time compared to baseline
- Secondary Outcome Measures
Name Time Method change in apnea-hypopnea index (AHI) two weeks after initiation of treatment mean AHI compared to baseline
change in snoring intensity two weeks after initiation of treatment mean dBC compared to baseline
Treatment-emergent adverse events two weeks tabulation of all adverse events during the clinical trial
change in Epworth Sleepiness Scale (ESS) two weeks after initiation of treatment mean ESS compared to baseline (total range 0-24; lower score means less sleepy)
Short Form Survey 36 (SF-36) one week time frame, administered two weeks after initiation of treatment mean SF-36 compared to baseline
Clinical Global Impression (CGI) Scale: Snorer's sleep previous week, assessed one and two weeks after initiation of treatment CGI "usual sleep score" vs baseline (score range "very much better to very much worse"
Clinical Global Impression (CGI) Scale: Bed partner's complaints about snoring previous week, assessed one and two weeks after initiation of treatment CGI "bed partner complaints about your snoring" scale vs baseline (score range "complained very much less, to "complained very much more"
Clinical Global Impression (CGI) Scale: Acceptability of cNEP "overall experience to date", assessed one and two weeks after initiation of treatment CGI "bed partner complaints about your snoring" scale vs baseline (score range "complained very much less, to "complained very much more"
Clinical Global Impression (CGI) Scale: Bed partner's impression of snorer's sleep previous week, assessed one and two weeks after initiation of treatment CGI scale comparing snorer's sleep to baseline (score range "very much better to very much worse"
Clinical Global Impression (CGI) Scales: bed partner's sleep previous week, assessed one and two weeks after initiation of treatment CGI scale comparing bed partner's sleep to baseline (score range "very much better to very much worse"
Clinical Global Impression (CGI) Scale: Bed partner's overall relationship with snorer previous week, assessed one and two weeks after initiation of treatment CGI scale comparing bed partner's overall relationship wtih snorer to baseline (score range "very much better to very much worse"
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Cleveland Clinic
🇺🇸Cleveland, Ohio, United States
Cleveland Clinic🇺🇸Cleveland, Ohio, United States